What did Ingersoll Rand pay for Controlled Fluidics?

Ingersoll Rand acquired Controlled Fluidics for $51.9M in 2024, equivalent to 5.20x revenue. Target revenue was approximately $10.0M.

What does Controlled Fluidics do?

Controlled Fluidics is a medical devices business.

What multiple did Ingersoll Rand pay for Controlled Fluidics?

5.20x revenue, based on disclosed deal value of $51.9M and disclosed financials.

M&A TRANSACTION · 2024

Controlled Fluidics acquired by Ingersoll Rand

$51.9M· 5.20x revenue

Target

Controlled Fluidics

Acquirer

Ingersoll Rand

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$10.0M

EBITDA

—

Deal Value

$51.9M

EV/EBITDA

—

Context

This $51.9M acquisition of Controlled Fluidics by Ingersoll Rand sits in the medical devices sub-vertical. Ingersoll Rand is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and investor presentations. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Controlled Fluidics acquisition.

Citation: ExitValue.ai. (2024). Controlled Fluidics acquired by Ingersoll Rand. https://exitvalue.ai/deals/controlled-fluidics-acquired-by-ingersoll-rand-hc-2024-0031